Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Condition:   Esophageal Cancer
Intervention:   Drug: SHR-1210
Sponsors:   Tianjin Medical University Cancer Institute and Hospital;   Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified July 2017

http://ift.tt/2tH58Mw